The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Cleveland, while others were found more universally (Group 2). Asthma exacerbations<br />
were lower in remediated homes compared to non-remediated homes. <strong>The</strong><br />
study objective was to compare the allergy induction potential <strong>of</strong> these groups <strong>of</strong><br />
molds to house dust mite (HDM) in our mouse allergy/asthma model. Female<br />
BALB/c mice received 1 or 4 exposures by intratracheal aspiration <strong>of</strong> mold or<br />
HDM extract (0-80 μg). Serum and bronchoalveolar lavage fluid (BALF) were collected<br />
2 days after the final exposure. <strong>The</strong> allergic impact <strong>of</strong> the various mold extract<br />
exposures was different for each regardless <strong>of</strong> its categorization. Multiple exposures<br />
were required to induce increased BALF eosinophil counts and serum total<br />
IgE. To achieve similar results to those induced by HDM in the antigen-specific<br />
IgE assay, Group 1 molds required 1.5X more Scopulariopsis brevicaulis (SBE) or<br />
6.7X more Trichoderma viride (TVE). Group 2 molds required: 0.2X as much<br />
Cladosporium cladosporiodes (CCE) or 2.3X more Epicoccum nigrum (ENE) to<br />
produce similar results Both CCE and ENE induced BALF eosinophil counts and<br />
responses to methacholine (Mch) challenge similar to or higher than HDM.<br />
Neither Penicillium crustosum (PCG, Group 1) nor Wallemia sebi (WSE, Group<br />
1) induced robust cellular or IgE responses but PCG did induce elevated responses<br />
to Mch challenge at the higher doses. <strong>The</strong> data suggest that the categorization <strong>of</strong><br />
certain molds as Group 1 or 2 does not indicate their capacity to induce allergic responses<br />
in a mouse model. However, the current study does not allow us to draw<br />
conclusions regarding the capacity <strong>of</strong> Group 1 and 2 molds to non-specifically exacerbate<br />
asthmatic responses. (This abstract does not reflect U.S. EPA policies.)<br />
299 THE INFLUENCE OF GENETIC BACKGROUND IN A<br />
MOUSE MODEL OF CHEMICAL-INDUCED<br />
OCCUPATIONAL ASTHMA.<br />
K. Luyts, V. De Vooght, B. Nemery, P. H. Hoet and J. A. Vanoirbeek. Research<br />
Unit for Lung <strong>Toxicology</strong>, K.U. Leuven, Leuven, Belgium.<br />
<strong>The</strong> development <strong>of</strong> occupational asthma is the result <strong>of</strong> interactions between environmental<br />
factors and individual susceptibility. In this study we assessed the influence<br />
<strong>of</strong> the genetic background - as present in different mouse strains - in a model<br />
<strong>of</strong> chemical-induced occupational asthma, using a typical respiratory sensitizer,<br />
toluene diisocyanate (TDI). On days 1 and 8, male mice <strong>of</strong> different strains<br />
(BALB/c, BP/2, A/J, C57Bl/6, DBA/2, CBA and AKR) were dermally treated with<br />
TDI (0.3%) or vehicle (acetone olive oil, AOO, 2:3) on each ear (20μl). On day<br />
15, they received an oropharyngeal challenge <strong>of</strong> TDI (0.01%) or AOO (1:4).<br />
Airway reactivity to methacholine was measured (pulmonary resistance) 22 h later.<br />
Total and differential cell counts, IL2, IL5, IL6, IL13, TNFα and KC were assessed<br />
in bronchoalveolar lavage (BAL) fluid. Total serum IgE and IgG2a levels were measured.<br />
Lymphocyte subpopulations (CD4, CD8, CD25 and CD19) in auricular<br />
lymph nodes and release <strong>of</strong> IL2, IL4, IL10, IL13 and IFNγ by lymphocytes were assessed.<br />
Airway hyperreactivity was observed in the TDI-treated BALB/c, BP/2, A/J<br />
and AKR mice. Airway inflammation was most pronounced in TDI-treated<br />
BALB/c mice compared to their own control. No significant differences in BAL cytokines<br />
were found. Numbers <strong>of</strong> helper T cells (CD4), activated T cells<br />
(CD4CD25), cytotoxic T cells (CD8) and B cells (CD19) were increased in the auricular<br />
lymph nodes <strong>of</strong> TDI-treated BALB/c, BP/2, A/J and CBA mice. In TDItreated<br />
BALB/c, BP/2, A/J, C57Bl/6 and CBA mice elevated concentrations <strong>of</strong> IL4,<br />
IL10, IL13 and IFNγ were detected in the supernatant <strong>of</strong> the auricular lymphocytes<br />
along with an increase in total serum IgE. <strong>The</strong>se experiments indicate that the genetic<br />
background has a large impact on different aspects <strong>of</strong> an asthmatic phenotype.<br />
In this model <strong>of</strong> chemical-induced occupational asthma, the human phenotype is<br />
best reflected by the BALB/c mice. Acknowledgments: <strong>The</strong> Interuniversity<br />
Attraction Pole Program (P6/35) and the Research Foundation - Flanders (FWO<br />
G.0547.08)<br />
300 COMPARISON OF LLNA RESPONSES BETWEEN CBA<br />
AND BALB/C MOUSE STRAINS.<br />
T. Burns 1 , J. Strickland 1 , E. Salicru 1 , D. Allen 1 and W. Stokes 2 . 1 ILS,<br />
Inc./NICEATM, NIEHS, Research Triangle Park, NC and 2 NICEATM, NIEHS,<br />
Research Triangle Park, NC.<br />
While CBA is currently the recommended strain for the LLNA, the assay was originally<br />
developed using BALB/c mice. Since the introduction <strong>of</strong> the LLNA, several<br />
groups have published LLNA studies using BALB/c mice, including the National<br />
<strong>Toxicology</strong> Program, the National Institute for Occupational Safety and Health,<br />
and the Dow Chemical Corporation. BALB/c mice are used in countries where<br />
CBA mice are difficult to obtain. This has resulted in reference databases for the<br />
LLNA that include studies conducted with both CBA and BALB/c mice. However,<br />
there is little published literature that directly compares the performance <strong>of</strong> the<br />
LLNA in studies done on the same substances in the two mouse strains. <strong>The</strong> study<br />
reported here is a retrospective evaluation <strong>of</strong> the performance <strong>of</strong> the LLNA when<br />
using CBA mice with those using BALB/c mice. NICEATM evaluated 108 independent<br />
studies representing 15 substances in four vehicles in which 86 studies<br />
used CBA mice and 22 used BALB/c mice. Thirteen <strong>of</strong> these substances had guinea<br />
pig reference data and 12 had human reference data. LLNA outcomes using<br />
BALB/c are in agreement with LLNA outcomes obtained with CBA for 87%<br />
(13/15) <strong>of</strong> the test substances. LLNA outcomes with CBA agree with guinea pig<br />
outcomes for 92% (12/13) <strong>of</strong> the test substances and with human outcomes for<br />
92% (11/12) <strong>of</strong> the test substances. LLNA outcomes with BALB/c agree with<br />
guinea pig outcomes for 77% (10/13) <strong>of</strong> the test substances and with human outcomes<br />
for 75% (9/12) <strong>of</strong> the test substances. A correlation analysis <strong>of</strong> log transformed<br />
EC3 values calculated using LLNA data from each <strong>of</strong> the two strains indicates<br />
that the results from the two strains are correlated (r = 0.75). Overall, these<br />
data indicate that LLNA outcomes do not differ appreciably when either CBA or<br />
BALB/c mice are used as test animals. ILS staff was supported by NIEHS contract<br />
N01-ES-35504.<br />
301 PREDICTION OF SKIN SENSITIZATION POTENTIAL<br />
OF CHEMICALS BY HUMAN CELL LINE ACTIVATION<br />
TEST (H-CLAT) AND AN ATTEMPT OF<br />
CLASSIFICATION OF SKIN SENSITIZATION POTENCY.<br />
Y. Nukada 1 , T. Ashikaga 2 ,T.Abo 1 , S. Sono 2 , H. Sakaguchi 1 , H. Itagaki 2 and<br />
N. Nishiyama 1 . 1 Kao Corporation, Tochigi, Japan and 2 Shiseido Co., Ltd.,<br />
Kanagawa, Japan.<br />
We have developed the h-CLAT, an in vitro skin sensitization test using THP-1<br />
cells (human monocytic leukemia cell line). This test is based on the augmentation<br />
<strong>of</strong> CD86 and CD54 expression in THP-1 cells following exposure to chemicals. In<br />
this study, we evaluated about 106 chemicals with different potentials <strong>of</strong> skin sensitization<br />
in the h-CLAT and compared our results with LLNA or human test data.<br />
Moreover, we tried to clarify the applicability domain <strong>of</strong> this method based on<br />
physico-chemical property. <strong>The</strong> accuracies <strong>of</strong> the h-CLAT vs. LLNA or human test<br />
data were about 84 % or 80%, respectively. Among several types <strong>of</strong> physico-chemical<br />
properties <strong>of</strong> each chemical, molecular weight, boiling point, melting point and<br />
Log Kow are not related to the applicability domain <strong>of</strong> the h-CLAT. On the other<br />
hand, many <strong>of</strong> false-negatives did not dissolve to the medium at the highest applying<br />
dose. <strong>The</strong>refore, it seems that in the current protocol <strong>of</strong> h-CLAT, poor solubility<br />
<strong>of</strong> samples to the medium is the most important limitation. We also evaluated<br />
the utility <strong>of</strong> h-CLAT to classify the skin sensitization potential by using various<br />
calculated values. From the data <strong>of</strong> 66 chemicals, which was both positive in h-<br />
CLAT and LLNA, several values were calculated as follow: 1) CV75, 2) maximum<br />
RFI <strong>of</strong> each chemical, 3) EC150, and 4) EC200. Correlational analyses between<br />
LLNA EC3 and the four values were performed. A statistically significant correlation<br />
was observed between CV75, EC150, and EC200 values with LLNA EC3.<br />
<strong>The</strong> EC150 value showed the better correlation compared to other values. From<br />
EC150 and EC200, Minimum Induction Threshold (MIT) was determined as a<br />
minimum value, smallest <strong>of</strong> either EC150 or EC200. MIT also show the good correlation<br />
with EC3. From these data, the h-CLAT values might be a one <strong>of</strong> the useful<br />
tool to predict the allergic potency <strong>of</strong> chemicals after improving the detailed<br />
conditions.<br />
302 ESTABLISHMENT OF AN EX VIVO METHOD TO<br />
DETECT ALLERGEN SPECIFIC IGE MEDIATED<br />
HISTAMINE RELEASE IN BASOPHILS FROM<br />
CYNOMOLGUS MONKEY WHOLE BLOOD.<br />
P. Skov 2 , A. Lucock 1 , S. Kirk 1 and D. Everett 1 . 1 Covance Laboratories Ltd.,<br />
Harrogate, North Yorkshire, United Kingdom and 2 RefLab ApS, Copenhagen,<br />
Denmark.<br />
Many biotechnology derived pharmaceuticals intended for human use have the potential<br />
to be immunogenic, especially in animals. During pre-clinical safety assessment<br />
it is important to determine if an antibody response has been made against<br />
the test substance and to determine if such a response has the potential to be detrimental.<br />
One possible outcome is that an immune response to a biological may generate<br />
IgE antibodies which can lead to a Type 1 hypersensitivity and the possibility<br />
<strong>of</strong> anaphylactic shock. When an antibody response against a test substance is established<br />
it is important to characterize this response and establish possible adverse<br />
consequences. In this study we have established a method which can measure IgE<br />
mediated release in basophils from cynomolgus monkey whole blood.<br />
White blood cells (WBC) including basophils were isolated from whole blood in<br />
EDTA, by dextran sedimentation, from 4 primates suspected <strong>of</strong> having a type I hypersensitivity<br />
reaction to a test substance designed for the treatment <strong>of</strong> clotting disorders.<br />
Harvested white blood cells were pre-incubated with IL-3, then aliquoted<br />
onto microtitre plates and incubated at 37°C for 1 hour. <strong>The</strong> experiment was designed<br />
such that WBC’s from each animal were incubated with 4 different batches<br />
SOT 2010 ANNUAL MEETING 65